You searched for "electives"

2032 results found

Sight Sciences Celebrates 150th Certified UK OMNI Surgeon

Sight Sciences is proud to announce that 150 ophthalmic surgeons in the United Kingdom are now certified to use the OMNI® Surgical System. This milestone was marked by the recent certification of Ms. Diana Urbaneja, Consultant Ophthalmic Surgeon at University...

Aspiration of anteriorly migrated dexamethasone implant using an 18G intravenous cannula

Intravitreal dexamethasone (Ozurdex 0.7mg) is a biodegradable, sustained-release implant used to manage diabetic macular oedema, macular oedema secondary to retinal vein occlusion, and non-infectious posterior uveitis due to its anti-inflammatory effects and VEGF suppression [1]. While effective, the implant may...

MacuMira and Keeler announce strategic partnership to expand dry AMD therapy

Keeler, a global leader in ophthalmic innovation with more than a century of heritage, and MacuMira Medical Devices Inc, a pioneering Canadian company, has announced a strategic partnership. Under the agreement, Keeler will manufacture the MacuMira device and lead its...

Marsha de Cordova MP presented with an Honorary Fellowship of The College of Optometrists

This week, The College of Optometrists formally presented Marsha de Cordova MP with an Honorary Fellowship at the College’s headquarters in London. Marsha de Cordova is the Labour MP for Battersea, a former Lambeth Councillor and a longstanding champion of...

Early vitrectomy for endophthalmitis offers hope to patients

A Phase 2 feasibility study published today in the prestigious Nature Communications Medicine journal has shown that early vitrectomy surgery treatment for acute endophthalmitis can be potentially more beneficial to patients’ vision compared with the current antibiotic-first approach. This is...

New Moorfields stem cell treatment improves vision for untreatable condition

A new breakthrough stem cell treatment for ARK (aniridia-related keratopathy) has seen patients’ vision improve for this previously untreatable rare genetic eye condition in a first-in-human clinical trial at Moorfields Eye Hospital and the UCL Institute of Ophthalmology, published in...

‘Let’s place focus on Scotland’s vast innovation opportunities during National Eye Health Week’

National Eye Health Week (NEHW) could provide essential inspiration for NHS Scotland staff looking to focus on fresh ophthalmic innovation, says InnoScot Health. This year's NEHW is taking place from 23 to 29 September under an inclusive theme of ‘Vision...

Acanthaemoeba keratitis

In the second of this series I describe a case of Acanthaemoeba keratitis (AK) that was misdiagnosed for a prolonged period which resulted in a devastating outcome. This is one of half a dozen similar medico-legal cases I have dealt...

What can artificial intelligence do to improve sustainability in the delivery of ophthalmic care?

The 2025 NHS 10-year plan, titled ‘Fit for the Future’, emphasises a significant shift from analogue to digital, with a strong focus on integrating AI and other technologies to transform healthcare. The plan aims to make the NHS the "most...

BOAS 2025 Annual Scientific Meeting

We are excited to announce the upcoming 23rd BOAS Annual Scientific Meeting, which will be held at the prestigious Royal Society of Medicine in London on Thursday 4th and Friday 5th September 2025. This event offers an exceptional opportunity for...

Game show freak

As a child of the 70s and 80s, there were limited television viewing opportunities. For the duration of the 70s there were only three channels, only moving to four with the launch of Channel 4 in 1982. Not only that,...

Conference Report: The Medical Ophthalmology Society UK (MOSUK) 26th Annual Meeting

The Medical Ophthalmology Society UK (MOSUK) held its 26th annual meeting on 26 February 2025 at the International Students House in Great Portland Street, London. Medical ophthalmology is a distinctive and holistic speciality that encompasses the investigation, diagnosis, and management...